Back to RA CAPITAL MANAGEMENT, L.P.

NAMS
Showing 8 of 14 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in NEWAMSTERDAM PHARMA COMPANY

RA CAPITAL MANAGEMENT, L.P. holds 9.6M shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), worth $305.7M as of 2026-Q1. NAMS represents 3.2% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$305.7M

Current Shares

9.6M

Total Value Change

+$150.8M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
9.6M
0.0%
$305.7M3.2%$30.41
0
2025-Q4
Decreased
9.6M
-5.8%
$335M3.4%$34.74
0
2025-Q3
Unchanged
10.1M
0.0%
$288.4M3.6%$27.52
0
2025-Q2
Unchanged
10.1M
0.0%
$183.6M3.1%$18.57
0
2025-Q1
Increased
10.1M
+14.6%
$207.5M3.5%$21.76
64
2024-Q4
Increased
8.8M
+9.7%
$227.3M3.0%$25.60
62
2024-Q3
Unchanged
8.1M
0.0%
$133.9M1.5%$16.23
0
2024-Q2
Increased
8.1M
+2.5%
$154.9M2.0%$19.21
53

Other major holders of NAMS: Capital World Investors, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used